Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Applied Therapeutics FY 2024 GAAP EPS $(0.76) Beats $(1.37) Estimate

Author: Benzinga Newsdesk | April 14, 2025 06:38pm
Applied Therapeutics (NASDAQ:APLT) reported quarterly losses of $(0.76) per share which beat the analyst consensus estimate of $(1.37) by 44.53 percent. This is a 46.48 percent increase over losses of $(1.42) per share from the same period last year.

Posted In: APLT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist